We Think Pure Biologics Spólka Akcyjna (WSE:PUR) Can Afford To Drive Business Growth
There's no doubt that money can be made by owning shares of unprofitable businesses. For example, biotech and mining...
Polish (WIG) Biotech Industry Analysis
UpdatedJan 21, 2022
DataAggregated Company Financials
Companies15
- 7D-2.0%
- 3M-19.7%
- 1Y-3.8%
- YTD-1.3%
Over the last 7 days, the Biotech industry has dropped 2.7%, driven by a pullback from Mabion of 7.3%. However, the industry is down 5.2% over the past year.
Industry Valuation and Performance
Has the Polish Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE |
|---|---|---|---|---|
| Fri, 21 Jan 2022 | zł3.6b | zł369.9m | -zł24,922,742.00 | 48.1x |
| Sun, 19 Dec 2021 | zł3.9b | zł369.9m | -zł24,922,742.00 | 49.2x |
| Tue, 16 Nov 2021 | zł3.6b | zł367.1m | zł91,715.00 | 35.1x |
| Thu, 14 Oct 2021 | zł3.7b | zł364.5m | -zł1,455,285.00 | 33.3x |
| Sat, 11 Sep 2021 | zł3.5b | zł364.5m | -zł1,456,285.00 | 37.7x |
| Mon, 09 Aug 2021 | zł3.6b | zł362.9m | -zł8,912,285.00 | 40.5x |
| Sun, 02 May 2021 | zł3.8b | zł373.1m | -zł6,705,220.00 | 122x |
| Wed, 03 Feb 2021 | zł1.6b | zł382.5m | zł56.4m | 110.3x |
| Sat, 07 Nov 2020 | zł2.1b | zł307.0m | -zł7,012,804.00 | 59.4x |
| Fri, 31 Jul 2020 | zł2.5b | zł289.2m | -zł30,736,114.00 | 37.7x |
| Mon, 04 May 2020 | zł851.1m | zł304.1m | -zł149,014,103.00 | 47.7x |
| Thu, 06 Feb 2020 | zł581.0m | zł295.6m | -zł128,943,953.00 | 36.7x |
| Sun, 10 Nov 2019 | zł592.9m | zł300.9m | -zł129,547,264.00 | 28.2x |
| Sat, 03 Aug 2019 | zł1.9b | zł302.3m | -zł201,837,301.00 | 31.6x |
| Tue, 07 May 2019 | zł1.6b | zł308.2m | -zł27,971,600.00 | 17.1x |
| Fri, 08 Feb 2019 | zł1.6b | zł316.8m | -zł76,312,329.00 | 16.7x |
PE Ratio
16.7x
Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 47.8x. It appears they believe that earnings will grow in-line with historical growth rates.
Past Earnings Growth: The earnings for companies in the Biotechs industry have improved over the last three years, and revenues for these companies have grown 5.3% per year. This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Polish Biotech industry?
| Biotech | -2.71% | |
Industry PE: Investors are most optimistic about the Biotech industry, which is trading close to its 3-year average PE ratio of 47.8x. However analysts are expecting annual earnings growth of 69%, which is lower than the prior year's growth of 106% per year. So the market might believe that analysts are underestimating future growth.
Forecasted Growth: Analysts are most optimistic on the Biotech industry, expecting annual earnings growth of 69% over the next 5 years. However this is lower than its past earnings growth rate of 106% per year.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| CTX Captor Therapeutics spolka akcyjna | zł184.00 | 2.2% +zł16.5m | n/a | n/a | |
| BLR BLIRT | zł9.96 | 10.7% +zł16.5m | -50.7% | PE8.9x | |
| RDG Read-Gene | zł3.10 | 14.8% +zł4.7m | 2.6% | PE51666.7x | |
| BCX Bioceltix | zł61.99 | 2.0% +zł3.9m | n/a | n/a | |
| BER Bioerg Spólka Akcyjna | zł0.18 | 0.9% +zł152.5k | -46.2% | PS3.6x |